Related Experiment Video
Updated: Jul 14, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease
N Mahmud1, G S McDonald, D Kelleher
1Department of Clinical Medicine, Trinity College, Dublin, Ireland.
Abstract:
It has previously been shown that microalbuminuria is a useful disease activity marker for inflammatory bowel disease (IBD). Microalbuminuria correlates strongly with the markers of clinical and laboratory disease activity such as erythrocyte sedimentation rate (ESR), and C reactive protein (CRP). The aim of this study was to discover if microalbuminuria accurately reflects the intestinal inflammation by correlating it with intestinal inflammation using a standard histopathological grading system in patients with ulcerative colitis and Crohn's colitis. Forty two patients with IBD who had undergone endoscopic examination of the entire colon for the assessment of severity and extent of the disease (Crohn's colitis (n = 21), ulcerative colitis (n = 21)) were recruited to the study. Patients with small bowel Crohn's disease were not studied. Twenty four patients had left sided colonic disease and 18 patients had extensive colonic disease. Each patient's colonic biopsy specimens were scored blindly by a histopathologist and a composite score was compiled on the basis of the severity of changes in the enterocytes and crypts and the cellularity of the lamina propria. A clinical disease activity was obtained using the simple index of Harvey and Bradshaw. Microalbuminuria was measured in all patients by an immunoturbiditimetric method. ESR and CRP were also measured, as indicators of acute phase response in the same patients. It was found that patients with active IBD had higher concentrations of microalbuminuria compared with those patients in remission (median 222 micrograms/min (range 40-686 micrograms/min) v median 96 micrograms/min (range 30-376 micrograms/min); p < 0.001)). Significantly higher concentrations of microalbuminuria were also detected in patients with extensive colonic IBD compared with those patients with left sided disease (median 297 micrograms/min (range 132-686 micrograms/min) v median 101 micrograms/min (range 30-433 micrograms/min); p < 0.001)). A strong positive correlation was seen between microalbuminuria and intestinal histopathological score in IBD patient groups with left sided colitis (r = 0.77; p < 0.001) and extensive disease (r = 0.71; p < 0.01). The standard histopathological grading system correlated with the clinical disease activity (r = 0.64; p < 0.005) and CRP (r = 0.62; p < 0.02), however, it did not correlate with ESR. In conclusion, the strong correlation of microalbuminuria with a standard intestinal histopathological grading system suggests that microalbuminuria accurately reflects the severity of colonic inflammation in patients with Crohn's colitis and ulcerative colitis.
Insights
Microalbuminuria effectively indicates disease activity in inflammatory bowel disease (IBD). This study confirms microalbuminuria correlates strongly with intestinal inflammation severity in ulcerative colitis and Crohn's colitis patients.
Area of Science:
- Gastroenterology
- Nephrology
- Pathology
Background:
- Microalbuminuria is recognized as a potential disease activity marker in inflammatory bowel disease (IBD).
- Previous studies show microalbuminuria correlates with clinical and laboratory markers like ESR and CRP.
- The relationship between microalbuminuria and direct measures of intestinal inflammation requires further investigation.
Purpose of the Study:
- To determine if microalbuminuria accurately reflects intestinal inflammation.
- To correlate microalbuminuria levels with histopathological grading of intestinal inflammation in IBD.
- To assess microalbuminuria as a marker in ulcerative colitis and Crohn's colitis.
Main Methods:
- 42 IBD patients (21 ulcerative colitis, 21 Crohn's colitis) underwent colonoscopy.
- Colonic biopsy specimens were histopathologically scored for inflammation severity.
- Microalbuminuria, ESR, and CRP levels were measured; clinical activity assessed using Harvey-Bradshaw index.
Main Results:
- Active IBD patients showed significantly higher microalbuminuria than those in remission (p < 0.001).
- Extensive colonic IBD correlated with higher microalbuminuria compared to left-sided disease (p < 0.001).
- Strong positive correlations were found between microalbuminuria and histopathological scores (r=0.77 for left-sided, r=0.71 for extensive disease).
Conclusions:
- Microalbuminuria strongly correlates with the histopathological severity of colonic inflammation in IBD.
- Microalbuminuria serves as an accurate indicator of colonic inflammation in ulcerative colitis and Crohn's colitis.
- This finding supports microalbuminuria's utility as a non-invasive marker for IBD disease activity.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations

